Drugreporter café

Study lead Balazs Szigeti presents the results of the self-blinding microdose study to Drugreporter.

Psychedelics today (podcast)

Study lead Balazs Szigeti and senior author, David Erritzoe, discusses the findings from the self-blinding microdose study with the Psychedelics Today team.

Is microdosing placebo?

Study lead Balazs Szigeti talks to the Brooklyn psychedelic society about the inspiration and reason behind the original self-blinding microdose study (study is now published; talk recorded 2019 June).

Study promo video